Consonance Capital Management as of March 31, 2014
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 27 positions in its portfolio as reported in the March 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) | 9.4 | $63M | 670k | 94.03 | |
Myriad Genetics (MYGN) | 8.9 | $60M | 1.7M | 34.19 | |
Furiex Pharmaceuticals | 8.0 | $54M | 617k | 87.00 | |
Enanta Pharmaceuticals (ENTA) | 7.5 | $50M | 1.3M | 39.99 | |
BioScrip | 5.2 | $35M | 5.0M | 6.98 | |
Aegerion Pharmaceuticals | 5.2 | $35M | 759k | 46.18 | |
Insys Therapeutics | 5.0 | $33M | 802k | 41.43 | |
Orthofix International Nv Com Stk | 4.9 | $33M | 1.1M | 30.15 | |
Anacor Pharmaceuticals In | 4.8 | $32M | 1.6M | 20.01 | |
Taro Pharmaceutical Industries (TARO) | 4.5 | $31M | 275k | 111.00 | |
Masimo Corporation (MASI) | 4.4 | $30M | 1.1M | 27.31 | |
Osiris Therapeutics | 4.0 | $27M | 2.1M | 13.13 | |
Hyperion Therapeutics | 3.9 | $27M | 1.0M | 25.80 | |
Vanda Pharmaceuticals (VNDA) | 3.0 | $20M | 1.2M | 16.25 | |
Intuitive Surgical (ISRG) | 2.4 | $16M | 37k | 437.98 | |
WuXi PharmaTech | 2.4 | $16M | 431k | 36.86 | |
Infinity Pharmaceuticals (INFIQ) | 2.2 | $15M | 1.3M | 11.89 | |
Flamel Technologies | 2.1 | $14M | 1.0M | 13.40 | |
Clovis Oncology | 2.1 | $14M | 201k | 69.27 | |
Galena Biopharma | 2.0 | $14M | 5.4M | 2.50 | |
Derma Sciences | 1.7 | $11M | 892k | 12.68 | |
Ophthotech | 1.6 | $11M | 311k | 35.67 | |
Healthways | 1.5 | $10M | 594k | 17.14 | |
Biosante Pharmaceuticals (ANIP) | 1.2 | $7.9M | 251k | 31.35 | |
Akorn | 1.0 | $6.5M | 295k | 22.00 | |
Pernix Therapeutics Holdings | 1.0 | $6.5M | 1.2M | 5.35 | |
Liposcience | 0.2 | $1.4M | 443k | 3.19 |